1. MIMS Australia (2008) Docetaxel (Taxotere). MIMS annual. MIMS Australia Pty Ltd, St Leonards, NSW
2. Gligorov J, Lotz JP (2004) Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 9(Supplement 2):3–8
3. Nagore E, Insa A, Sanmartin O (2000) Antineoplastic therapy-induced palmar plantar erythrodysesthesia (hand–foot syndrome): incidence, recognition and management. Am J Clin Derm 1:225–234
4. Winther D, Saunte DM, Knap M, Haahr V, Jensen AB (2007) Nail changes associated with docetaxel chemotherapy: a neglected side effect. 14th European Cancer Conference. Eur Oncol Soc, Barcelona
5. Zimmerman GC, Keeling JH, Burris HA, Cook G, Irvin R, Kuhn J et al (1995) Acute cutaneous reactions to Docetaxel, a new chemotherapeutic agent. Dermatology 131(2):4